RTTNews | Jul 12, 2021 08:06AM EDT

08:05 Monday, July 12, 2021 (RTTNews) - Arcutis Enrolls 1st Patient In Phase 3 Trial Of Topical Roflumilast As Potential Treatment For Seborrheic Dermatitis

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved